Literature DB >> 22763426

Frontal and periventricular brain white matter lesions and cortical deafferentation of cholinergic and other neuromodulatory axonal projections.

N I Bohnen1, C W Bogan, M L T M Müller.   

Abstract

White matter fiber bundles form a spatial pattern defined by anatomical and functional architecture. Structural lesions in the white matter may cause clinical symptoms because of disruption of fiber tracts. The clinical significance will depend on the anatomic location of such lesions and whether the functional integrity of specific fiber bundles is affected. Unlike more acute lesions of stroke or multiple sclerosis that may cause sudden sensorimotor deficits, white matter lesions of aging manifest with more subtle and gradual symptoms that are often cognitive in nature. Such cognitive symptoms have been explained by strategically located white matter lesions in the deep forebrain that may disrupt cholinergic projection fibers at their proximal origin. Recent in vivo imaging studies provide supportive evidence that periventricular white matter lesions are associated with cortical cholinergic deafferentation in elderly with leukoaraiosis. White matter lesions at the frontal horns, so-called "capping," are in close proximity to cholinergic axons that originate in the basal forebrain. Therefore, these lesions may result in more significant cortical deafferentation because of the more proximal axonal disruption. A unique anatomic feature common to all cortical projections from subcortical neuromodulator systems (that not only include the cholinergic but also the monoaminergic systems, such as dopamine, serotonin, and norepinephrine) is that the proximal axons largely pass through the deep forebrain before fanning out to the cortex. It is thus plausible that deep frontal white matter lesions may result in not only cholinergic but also variable monoaminergic cortical deafferentation.

Entities:  

Year:  2009        PMID: 22763426      PMCID: PMC3387993     

Source DB:  PubMed          Journal:  Eur Neurol J


  43 in total

1.  Association of gait and balance disorders with age-related white matter changes: the LADIS study.

Authors:  H Baezner; C Blahak; A Poggesi; L Pantoni; D Inzitari; H Chabriat; T Erkinjuntti; F Fazekas; J M Ferro; P Langhorne; J O'Brien; P Scheltens; M C Visser; L O Wahlund; G Waldemar; A Wallin; M G Hennerici
Journal:  Neurology       Date:  2008-03-18       Impact factor: 9.910

2.  Stereotaxic mapping of the monoamine pathways in the rat brain.

Authors:  U Ungerstedt
Journal:  Acta Physiol Scand Suppl       Date:  1971

3.  Visualization of the vesicular acetylcholine transporter in cholinergic nerve terminals and its targeting to a specific population of small synaptic vesicles.

Authors:  E Weihe; J H Tao-Cheng; M K Schäfer; J D Erickson; L E Eiden
Journal:  Proc Natl Acad Sci U S A       Date:  1996-04-16       Impact factor: 11.205

4.  A new visual rating scale to assess strategic white matter hyperintensities within cholinergic pathways in dementia.

Authors:  Christian Bocti; Richard H Swartz; Fu-Qiang Gao; Demetrios J Sahlas; Pearl Behl; Sandra E Black
Journal:  Stroke       Date:  2005-09-22       Impact factor: 7.914

5.  Clinical correlates of white matter findings on cranial magnetic resonance imaging of 3301 elderly people. The Cardiovascular Health Study.

Authors:  W T Longstreth; T A Manolio; A Arnold; G L Burke; N Bryan; C A Jungreis; P L Enright; D O'Leary; L Fried
Journal:  Stroke       Date:  1996-08       Impact factor: 7.914

6.  Measurement of acetylcholinesterase by positron emission tomography in the brains of healthy controls and patients with Alzheimer's disease.

Authors:  M Iyo; H Namba; K Fukushi; H Shinotoh; S Nagatsuka; T Suhara; Y Sudo; K Suzuki; T Irie
Journal:  Lancet       Date:  1997-06-21       Impact factor: 79.321

7.  Kinetic analysis of [(11)C]MP4A using a high-radioactivity brain region that represents an integrated input function for measurement of cerebral acetylcholinesterase activity without arterial blood sampling.

Authors:  S Nagatsuka Si; K Fukushi; H Shinotoh; H Namba; M Iyo; N Tanaka; A Aotsuka; T Ota; S Tanada; T Irie
Journal:  J Cereb Blood Flow Metab       Date:  2001-11       Impact factor: 6.200

8.  Overlap between acetylcholinesterase-rich and choline acetyltransferase-positive (cholinergic) axons in human cerebral cortex.

Authors:  M M Mesulam; C Geula
Journal:  Brain Res       Date:  1992-04-10       Impact factor: 3.252

9.  White matter lesion extension to automatic brain tissue segmentation on MRI.

Authors:  Renske de Boer; Henri A Vrooman; Fedde van der Lijn; Meike W Vernooij; M Arfan Ikram; Aad van der Lugt; Monique M B Breteler; Wiro J Niessen
Journal:  Neuroimage       Date:  2009-05-01       Impact factor: 6.556

10.  MR signal abnormalities at 1.5 T in Alzheimer's dementia and normal aging.

Authors:  F Fazekas; J B Chawluk; A Alavi; H I Hurtig; R A Zimmerman
Journal:  AJR Am J Roentgenol       Date:  1987-08       Impact factor: 3.959

View more
  14 in total

1.  Modifiable cardiovascular risk factors and axial motor impairments in Parkinson disease.

Authors:  Vikas Kotagal; Roger L Albin; Martijn L T M Müller; Robert A Koeppe; Kirk A Frey; Nicolaas I Bohnen
Journal:  Neurology       Date:  2014-03-28       Impact factor: 9.910

2.  Leucoaraiosis, nigrostriatal denervation and motor symptoms in Parkinson's disease.

Authors:  Nicolaas I Bohnen; Martijn L T M Müller; Natalia Zarzhevsky; Robert A Koeppe; Christopher W Bogan; Michael R Kilbourn; Kirk A Frey; Roger L Albin
Journal:  Brain       Date:  2011-06-08       Impact factor: 13.501

3.  Cortical Implications of Advancing Age and Disease Duration in Parkinson's Disease Patients with Postural Instability and Gait Dysfunction.

Authors:  Joshua N Herb; Swati Rane; David A Isaacs; Nelleke Van Wouwe; Olivia C Roman; Bennett A Landman; Benoit M Dawant; Peter Hedera; David H Zald; Joseph S Neimat; Scott A Wylie; Manus J Donahue; Daniel O Claassen
Journal:  J Parkinsons Dis       Date:  2016-05-05       Impact factor: 5.568

Review 4.  White matter lesions in Parkinson disease.

Authors:  Nicolaas I Bohnen; Roger L Albin
Journal:  Nat Rev Neurol       Date:  2011-02-22       Impact factor: 42.937

5.  Advanced age, cardiovascular risk burden, and timed up and go test performance in Parkinson disease.

Authors:  Vikas Kotagal; Roger L Albin; Martijn L T M Müller; Robert A Koeppe; Stephanie Studenski; Kirk A Frey; Nicolaas I Bohnen
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2014-05-26       Impact factor: 6.053

6.  Educational attainment and motor burden in Parkinson's disease.

Authors:  Vikas Kotagal; Nicolaas I Bohnen; Martijn L T M Müller; Robert A Koeppe; Kirk A Frey; Kenneth M Langa; Roger L Albin
Journal:  Mov Disord       Date:  2015-06-10       Impact factor: 10.338

7.  The Attenuating Effect of Beta-Carotene on Streptozotocin Induced Diabetic Vascular Dementia Symptoms in Rats.

Authors:  Khian Giap Lim; Rajavel Varatharajan; Arunachalam Muthuraman
Journal:  Molecules       Date:  2022-07-04       Impact factor: 4.927

8.  Diabetes is associated with postural instability and gait difficulty in Parkinson disease.

Authors:  Vikas Kotagal; Roger L Albin; Martijn L T M Müller; Robert A Koeppe; Kirk A Frey; Nicolaas I Bohnen
Journal:  Parkinsonism Relat Disord       Date:  2013-02-23       Impact factor: 4.891

9.  Is the Location of White Matter Lesions Important in the Swallowing Function of Older Patients with Mild Stroke?

Authors:  Hyun Im Moon; Gyu Seong Kim; Eunchae Lee
Journal:  Dysphagia       Date:  2018-10-31       Impact factor: 3.438

10.  Role of cognitive enhancer therapy in Alzheimer's disease with concomitant cerebral white matter disease: findings from a long-term naturalistic study.

Authors:  Kok Pin Ng; Aloysius Ng; Pryseley Assam; Esther Heng; Nagaendran Kandiah
Journal:  Drugs R D       Date:  2014-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.